<?xml version="1.0" encoding="UTF-8"?>
<p>Dual effects of IFN-I have been observed in HCoV infections, as mentioned previously. A series of case studies describing moderate and severe MERS-CoV infections in adults found that moderate cases had no IFN-
 <italic>α</italic> response, while severe cases had variable levels of IFN-
 <italic>α</italic> [
 <xref rid="B288" ref-type="bibr">288</xref>]. However, other studies have shown that MERS-CoV and SARS-CoV patients improved with IFN-
 <italic>α</italic> therapy [
 <xref rid="B289" ref-type="bibr">289</xref>, 
 <xref rid="B290" ref-type="bibr">290</xref>].
</p>
